科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/17 | 3,838 | 3,958 | 3,831 | 3,870 | +3 | +0.1% | 209,200 |
| 2025/06/16 | 3,880 | 3,892 | 3,845 | 3,867 | +12 | +0.3% | 80,600 |
| 2025/06/13 | 3,876 | 3,897 | 3,839 | 3,855 | -18 | -0.5% | 115,900 |
| 2025/06/12 | 3,842 | 3,873 | 3,834 | 3,873 | +31 | +0.8% | 173,500 |
| 2025/06/11 | 3,859 | 3,883 | 3,828 | 3,842 | -3 | -0.1% | 90,700 |
| 2025/06/10 | 3,821 | 3,860 | 3,814 | 3,845 | +25 | +0.7% | 120,200 |
| 2025/06/09 | 3,820 | 3,824 | 3,784 | 3,820 | +35 | +0.9% | 111,500 |
| 2025/06/06 | 3,786 | 3,803 | 3,754 | 3,785 | +8 | +0.2% | 142,800 |
| 2025/06/05 | 3,786 | 3,787 | 3,740 | 3,777 | -33 | -0.9% | 127,800 |
| 2025/06/04 | 3,787 | 3,826 | 3,784 | 3,810 | +28 | +0.7% | 136,600 |
| 2025/06/03 | 3,770 | 3,796 | 3,746 | 3,782 | -5 | -0.1% | 95,800 |
| 2025/06/02 | 3,830 | 3,838 | 3,771 | 3,787 | -57 | -1.5% | 168,900 |
| 2025/05/30 | 3,795 | 3,860 | 3,795 | 3,844 | +33 | +0.9% | 197,000 |
| 2025/05/29 | 3,718 | 3,862 | 3,710 | 3,811 | +88 | +2.4% | 201,700 |
| 2025/05/28 | 3,764 | 3,776 | 3,719 | 3,723 | -41 | -1.1% | 162,100 |
| 2025/05/27 | 3,764 | 3,775 | 3,753 | 3,764 | ±0 | ±0% | 122,900 |
| 2025/05/26 | 3,740 | 3,783 | 3,731 | 3,764 | +26 | +0.7% | 121,400 |
| 2025/05/23 | 3,730 | 3,751 | 3,706 | 3,738 | ±0 | ±0% | 113,000 |
| 2025/05/22 | 3,735 | 3,764 | 3,699 | 3,738 | +18 | +0.5% | 148,800 |
| 2025/05/21 | 3,735 | 3,744 | 3,700 | 3,720 | +15 | +0.4% | 196,200 |
| 2025/05/20 | 3,757 | 3,757 | 3,694 | 3,705 | -52 | -1.4% | 223,600 |
| 2025/05/19 | 3,700 | 3,757 | 3,676 | 3,757 | +32 | +0.9% | 185,600 |
| 2025/05/16 | 3,748 | 3,755 | 3,664 | 3,725 | +40 | +1.1% | 250,000 |
| 2025/05/15 | 3,741 | 3,769 | 3,651 | 3,685 | -68 | -1.8% | 222,600 |
| 2025/05/14 | 3,733 | 3,753 | 3,681 | 3,753 | -42 | -1.1% | 281,300 |
| 2025/05/13 | 3,810 | 3,834 | 3,700 | 3,795 | -72 | -1.9% | 312,600 |
| 2025/05/12 | 4,007 | 4,039 | 3,845 | 3,867 | -143 | -3.6% | 264,200 |
| 2025/05/09 | 4,037 | 4,049 | 4,010 | 4,010 | +10 | +0.3% | 191,400 |
| 2025/05/08 | 4,061 | 4,061 | 4,000 | 4,000 | -55 | -1.4% | 139,000 |
| 2025/05/07 | 4,072 | 4,075 | 3,997 | 4,055 | -17 | -0.4% | 164,000 |
| 2025/05/02 | 4,070 | 4,093 | 4,035 | 4,072 | +31 | +0.8% | 130,200 |
| 2025/05/01 | 4,065 | 4,065 | 4,016 | 4,041 | -24 | -0.6% | 114,700 |
| 2025/04/30 | 4,046 | 4,068 | 4,010 | 4,065 | +44 | +1.1% | 118,800 |
| 2025/04/28 | 4,010 | 4,068 | 4,004 | 4,021 | +7 | +0.2% | 116,400 |
| 2025/04/25 | 4,058 | 4,058 | 3,998 | 4,014 | -35 | -0.9% | 128,200 |
| 2025/04/24 | 4,125 | 4,140 | 4,031 | 4,049 | -84 | -2% | 123,600 |
| 2025/04/23 | 4,140 | 4,176 | 4,115 | 4,133 | -7 | -0.2% | 146,800 |
| 2025/04/22 | 4,105 | 4,176 | 4,105 | 4,140 | +31 | +0.8% | 125,300 |
| 2025/04/21 | 4,067 | 4,124 | 4,046 | 4,109 | +18 | +0.4% | 122,300 |
| 2025/04/18 | 4,052 | 4,100 | 4,042 | 4,091 | +71 | +1.8% | 80,900 |
| 2025/04/17 | 4,009 | 4,020 | 3,959 | 4,020 | +10 | +0.2% | 87,900 |
| 2025/04/16 | 4,035 | 4,065 | 3,985 | 4,010 | -16 | -0.4% | 158,800 |
| 2025/04/15 | 4,008 | 4,077 | 3,991 | 4,026 | +48 | +1.2% | 132,400 |
| 2025/04/14 | 4,086 | 4,097 | 3,971 | 3,978 | -38 | -0.9% | 262,800 |
| 2025/04/11 | 4,165 | 4,165 | 3,995 | 4,016 | -359 | -8.2% | 381,100 |
| 2025/04/10 | 4,405 | 4,410 | 4,290 | 4,375 | +180 | +4.3% | 262,800 |
| 2025/04/09 | 4,465 | 4,485 | 4,095 | 4,195 | -270 | -6% | 450,500 |
| 2025/04/08 | 4,400 | 4,465 | 4,313 | 4,465 | +129 | +3% | 332,900 |
| 2025/04/07 | 4,244 | 4,405 | 4,164 | 4,336 | -105 | -2.4% | 399,200 |
| 2025/04/04 | 4,433 | 4,459 | 4,369 | 4,441 | +8 | +0.2% | 174,500 |
1～
50
件表示中 / 3722件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 387,000円 | -6.4% | -71.8% | 4.91% | 43.10倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 298,900円 | +7.9% | -3.3% | 2.68% | 8.31倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,100円 | +3.1% | -6.5% | 2.36% | 9.42倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
